As of 2025-11-25, the Intrinsic Value of Adicet Bio Inc (ACET) is -3.50 USD. This Adicet valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.61 USD, the upside of Adicet Bio Inc is -672.18%.
Based on its market price of 0.61 USD and our intrinsic valuation, Adicet Bio Inc (ACET) is overvalued by 672.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.50 - -3.50 | -3.50 | -672.18% |
| P/E | (10.03) - (13.46) | (12.44) | -2131.2% |
| DDM - Stable | (3.82) - (16.28) | (10.05) | -1741.4% |
| DDM - Multi | (0.06) - (0.20) | (0.09) | -115.2% |
| Market Cap (mil) | 103.29 |
| Beta | 1.62 |
| Outstanding shares (mil) | 168.73 |
| Enterprise Value (mil) | 75.16 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.36% |
| Cost of Debt | 5.00% |
| WACC | 8.02% |